대한한방내과학회지 제4 0 권 2 호( 2 0 1 9 년 5 월) J .I n t .K o r e a nMe d .2 0 1 9 ; 4 0 ( 2 ) : 2 7 0 -2 7 8 h t t p : / / d x . d o i . o r g / 1 0 . 2 2 2 4 6 / j i k m. 2 0 1 9 . 4 0 . 2 . 2 7 0 2 7 0 ․투고일:2 0 1 9 . 0 3 . 2 8 ,심사일:2 0 1 9 . 0 5 . 3 1 ,게재확정일:2 0 1 9 . 0 5 . 3 1 ․교신저자:권승원 서울시 동대문구 회기동 1 번지 경희대학교 한방병원 순환신경내과학교실 TEL:0 2 -9 5 8 -9 2 7 5 FAX:0 2 -9 5 8 -9 1 3 2 E-ma i l :k k o k k o t t u n g @h a n ma i l . n e t

This study consisted of a single centre randomised controlled trial with two parallel arms: an acupuncture group ( = 20) with 27 affected eyes and a sham group ( = 20) with 23 affected eyes. Participants in the acupuncture group received acupuncture treatment once daily, three times weekly for four weeks. Participants assigned to the control group received sham acupuncture, the same protocol as that used for the acupuncture group but without insertion of needles into the skin. The primary outcome measure was the cervical range of motion (CROM) score. Secondary outcome measures were the palpebral fissure size, response rate, and adverse events. All 40 participants completed the study. In the comparison of acupuncture and sham acupuncture, a significant difference was observed between acupuncture and sham acupuncture in CROM score (21.37 ± 15.16 and 32.21 ± 19.54, resp.) ( < 0.05) and palpebral fissure size (7.19 ± 2.94 and 5.41 ± 2.45, resp.) ( < 0.05). Response rate was also significantly different in the acupuncture group ( < 0.05). No adverse events were reported in both groups in this study. In summary, it was demonstrated that acupuncture had a feasibility positive effect on oculomotor paralysis.

No abstract

Goreisan is a herbal Kampo medicine used for treating chronic subdural hematoma (CSDH) in Japan. Experimental studies have suggested that Goreisan exerts a hydrogogue effect, but clinical evidence for the effectiveness of Goreisan in CSDH is currently lacking. Using a national Japanese inpatient database, we examined the association between Goreisan use and reoperation rates after burr-hole surgery for CSDH. We identified 36,020 patients, including 3,889 Goreisan users and 32,131 nonusers. Propensity scores of receiving Goreisan were calculated based on hospital characteristics and patient backgrounds (age, sex, body mass index, activities of daily living, consciousness level, comorbidities, antithrombotic agent use, mannitol infusion, and corticosteroid infusion). Oneto-one propensity-score matching created 3,879 pairs of Goreisan users and nonusers. Propensity-matched analysis revealed that Goreisan use was significantly associated with a lower reoperation rate (4.8%) compared with nonuse (6.2%) (risk difference, −1.4%; 95% confidence interval (CI), −2.4% to −0.38%). The number needed to prevent one reoperation was 72 (95% CI, 41-265). Instrumental-variable analysis showed similar results to the propensity-matched analysis. These results suggest that Goreisan use reduced the need for reoperation after burr-hole surgery for CSDH.

A case of a 72-year-old Korean male with herpes zoster ophthalmicus revealed. He was treated with Korean-Western cooperative treatment. We used the Numeric Rating Scale (NRS) to evaluate forehead and eye pain. Pain was improved after the administration of Korean medical treatments and disappeared after eight days. Korean-Western cooperative treatment may be effective in treating acute herpes zoster ophthalmicus.